| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |